Bombay Super Hybrid Seeds Ltd
₹ 106
1.17%
30 Dec
- close price
- Market Cap ₹ 1,109 Cr.
- Current Price ₹ 106
- High / Low ₹ 180 / 94.2
- Stock P/E 40.0
- Book Value ₹ 11.4
- Dividend Yield 0.00 %
- ROCE 21.2 %
- ROE 28.8 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company has delivered good profit growth of 58.2% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 31.6%
- Company's median sales growth is 18.9% of last 10 years
Cons
- Stock is trading at 9.28 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 | 63 | 110 | 82 | 75 | 103 | 171 | 191 | 228 | 256 | 358 | 354 | |
| 30 | 62 | 108 | 79 | 70 | 97 | 162 | 178 | 206 | 228 | 325 | 318 | |
| Operating Profit | 1 | 1 | 1 | 3 | 4 | 6 | 9 | 14 | 22 | 28 | 33 | 36 |
| OPM % | 3% | 2% | 1% | 4% | 6% | 6% | 5% | 7% | 9% | 11% | 9% | 10% |
| 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 2 | |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 5 | 6 | 7 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 0 | 0 | 1 | 2 | 3 | 3 | 6 | 11 | 18 | 24 | 28 | 29 |
| Tax % | 62% | 37% | 34% | 35% | 26% | 23% | 5% | 5% | 6% | 6% | 6% | |
| 0 | 0 | 1 | 1 | 2 | 3 | 6 | 10 | 17 | 22 | 26 | 28 | |
| EPS in Rs | 0.01 | 0.05 | 0.16 | 0.15 | 0.20 | 0.25 | 0.55 | 1.00 | 1.60 | 2.12 | 2.52 | 2.64 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 28% |
| 3 Years: | 23% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 91% |
| 5 Years: | 58% |
| 3 Years: | 36% |
| TTM: | 20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 63% |
| 3 Years: | -23% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 31% |
| 3 Years: | 32% |
| Last Year: | 29% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 3 | 3 | 5 | 7 | 8 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 0 | 0 | 1 | 3 | 14 | 15 | 18 | 29 | 46 | 68 | 94 | 109 |
| 6 | 7 | 12 | 16 | 13 | 16 | 30 | 39 | 53 | 48 | 92 | 30 | |
| 1 | 4 | 4 | 7 | 4 | 8 | 13 | 19 | 24 | 36 | 25 | 14 | |
| Total Liabilities | 8 | 15 | 20 | 31 | 38 | 47 | 73 | 98 | 133 | 162 | 222 | 163 |
| 2 | 3 | 5 | 4 | 9 | 9 | 8 | 7 | 9 | 7 | 9 | 11 | |
| CWIP | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 7 | 12 | 15 | 24 | 29 | 38 | 64 | 91 | 124 | 155 | 213 | 151 | |
| Total Assets | 8 | 15 | 20 | 31 | 38 | 47 | 73 | 98 | 133 | 162 | 222 | 163 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | -2 | -5 | -0 | -8 | -12 | -8 | 12 | -31 | |||
| -3 | -2 | -3 | -1 | -1 | -0 | -3 | -2 | -7 | |||
| 2 | 5 | 7 | 1 | 14 | 7 | 10 | -9 | 38 | |||
| Net Cash Flow | -0 | 2 | -2 | 0 | 5 | -5 | -0 | 0 | -0 |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 17 | 15 | 12 | 19 | 15 | 25 | 16 | 31 | 14 | 14 | 7 |
| Inventory Days | 55 | 50 | 30 | 71 | 143 | 121 | 169 | 281 | 497 | 406 | 349 |
| Days Payable | 3 | 12 | 8 | 13 | 5 | 6 | 7 | 30 | 51 | 27 | 22 |
| Cash Conversion Cycle | 70 | 52 | 34 | 76 | 152 | 140 | 179 | 282 | 460 | 393 | 335 |
| Working Capital Days | 12 | 11 | 11 | 35 | 69 | 61 | 39 | 63 | 77 | 102 | 98 |
| ROCE % | 10% | 15% | 14% | 13% | 13% | 15% | 19% | 22% | 24% | 21% |
Documents
Announcements
-
Trading Window
29 December 2025 - Trading window closed from Jan 1, 2026 until 48 hours after unaudited results for quarter/nine months ending Dec 31, 2025.
-
Copy of Newspaper Publication
10 November 2025 - Unaudited financials for quarter and half year ended Sep 30, 2025 approved Nov 8; published Nov 10, 2025.
-
Outcome of Board Meeting
8 November 2025 - Board approved unaudited Q2/H1 financial results ended 30 Sep 2025; auditor review issued 08 Nov 2025.
-
Outcome of Board Meeting
8 November 2025 - Board approved unaudited standalone Q2 results for quarter/half-year ended 30 Sep 2025; auditor issued clean review.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
19 October 2025 - RTA certificate: no physical share certificates received for dematerialisation for quarter ended 30 Sep 2025.
Product Portfolio
The company is engaged in the production, processing, and marketing of hybrid and GM seeds. It offers a range of over 150 products, including field crops and vegetable crops such as groundnut, chickpea, coriander, sesame, and maize. [1] [2] [3] [4]